EP2046342A4 - Forme cristalline a de l'acide ibandronique et son procédé de préparation - Google Patents
Forme cristalline a de l'acide ibandronique et son procédé de préparationInfo
- Publication number
- EP2046342A4 EP2046342A4 EP07813544A EP07813544A EP2046342A4 EP 2046342 A4 EP2046342 A4 EP 2046342A4 EP 07813544 A EP07813544 A EP 07813544A EP 07813544 A EP07813544 A EP 07813544A EP 2046342 A4 EP2046342 A4 EP 2046342A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- preparation
- crystalline form
- ibandronic acid
- ibandronic
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- MPBVHIBUJCELCL-UHFFFAOYSA-N Ibandronate Chemical compound CCCCCN(C)CCC(O)(P(O)(O)=O)P(O)(O)=O MPBVHIBUJCELCL-UHFFFAOYSA-N 0.000 title 1
- 229960005236 ibandronic acid Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
- C07F9/3839—Polyphosphonic acids
- C07F9/3873—Polyphosphonic acids containing nitrogen substituent, e.g. N.....H or N-hydrocarbon group which can be substituted by halogen or nitro(so), N.....O, N.....S, N.....C(=X)- (X =O, S), N.....N, N...C(=X)...N (X =O, S)
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US82063806P | 2006-07-28 | 2006-07-28 | |
| PCT/US2007/074738 WO2008014510A2 (fr) | 2006-07-28 | 2007-07-30 | Forme cristalline a de l'acide ibandronique et son procédé de préparation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP2046342A2 EP2046342A2 (fr) | 2009-04-15 |
| EP2046342A4 true EP2046342A4 (fr) | 2011-05-04 |
Family
ID=38982427
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP07813544A Withdrawn EP2046342A4 (fr) | 2006-07-28 | 2007-07-30 | Forme cristalline a de l'acide ibandronique et son procédé de préparation |
Country Status (2)
| Country | Link |
|---|---|
| EP (1) | EP2046342A4 (fr) |
| WO (1) | WO2008014510A2 (fr) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0810408A2 (pt) * | 2007-04-19 | 2014-11-04 | Reddys Lab Ltd Dr | Polimorfos de ibandronaro de sódio |
| WO2009042179A1 (fr) * | 2007-09-24 | 2009-04-02 | Teva Pharmaceutical Industries Ltd. | Formes cristallines de l'acide ibandronique et procédés pour la préparation de celles-ci |
| EP2609101B1 (fr) * | 2010-07-14 | 2015-01-28 | Pharmathen S.A. | Procédé de synthèse du sel d'acide 3-(n-méthyl-n-pentyl)amino-1-hydroxypropane-1,1-diphosphonique ou de ses dérivés |
| TR201200588A2 (tr) * | 2012-01-18 | 2012-07-23 | Koçak Farma İlaç Ve Ki̇mya Sanayi̇ Anoni̇m Şi̇rketi̇ | Sodyum ibandronat monohidrat polimorflarini ve polimorflu karışımlarını hazırlamak için prosesler. |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005063779A2 (fr) * | 2003-12-23 | 2005-07-14 | Lyogen Limited | Procede de preparation d'acides alkyl- et aryl-diphosphoniques et sels de ceux-ci |
| WO2006002348A2 (fr) * | 2004-06-23 | 2006-01-05 | Teva Pharmaceutical Industies Ltd. | Acide ibandronique solide et cristalline |
| WO2006024024A2 (fr) * | 2004-08-23 | 2006-03-02 | Teva Pharmaceutical Industries Ltd. | Sodium d'ibandronate solide cristallin et ses procedes de preparation |
| WO2006045578A2 (fr) * | 2004-10-29 | 2006-05-04 | F. Hoffmann-La Roche Ag | Procede servant a preparer des bisphosphonates |
| WO2007074475A2 (fr) * | 2005-12-27 | 2007-07-05 | Natco Pharma Limited | Nouvelles formes polymorphes de l'ibandronate |
-
2007
- 2007-07-30 EP EP07813544A patent/EP2046342A4/fr not_active Withdrawn
- 2007-07-30 WO PCT/US2007/074738 patent/WO2008014510A2/fr not_active Ceased
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005063779A2 (fr) * | 2003-12-23 | 2005-07-14 | Lyogen Limited | Procede de preparation d'acides alkyl- et aryl-diphosphoniques et sels de ceux-ci |
| WO2006002348A2 (fr) * | 2004-06-23 | 2006-01-05 | Teva Pharmaceutical Industies Ltd. | Acide ibandronique solide et cristalline |
| WO2006024024A2 (fr) * | 2004-08-23 | 2006-03-02 | Teva Pharmaceutical Industries Ltd. | Sodium d'ibandronate solide cristallin et ses procedes de preparation |
| WO2006045578A2 (fr) * | 2004-10-29 | 2006-05-04 | F. Hoffmann-La Roche Ag | Procede servant a preparer des bisphosphonates |
| WO2007074475A2 (fr) * | 2005-12-27 | 2007-07-05 | Natco Pharma Limited | Nouvelles formes polymorphes de l'ibandronate |
Non-Patent Citations (2)
| Title |
|---|
| CAIRA M R: "CRYSTALLINE POLYMORPHISM OF ORGANIC COMPOUNDS", TOPICS IN CURRENT CHEMISTRY, SPRINGER, BERLIN, DE, vol. 198, 1 January 1998 (1998-01-01), pages 163 - 208, XP001156954, ISSN: 0340-1022, ISBN: 978-3-540-36760-4, DOI: 10.1007/3-540-69178-2_5 * |
| DING C Z ET AL: "Transformation of monoamine oxidase-B primary amine substrates into time- dependent inhibitors. Tertiary amine homologues of primary amine substrates", JOURNAL OF MEDICINAL CHEMISTRY 1993 US, vol. 36, no. 12, 1993, pages 1711 - 1715, XP002629189, ISSN: 0022-2623 * |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2008014510A2 (fr) | 2008-01-31 |
| WO2008014510A3 (fr) | 2008-11-20 |
| EP2046342A2 (fr) | 2009-04-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA200904311B (en) | Process for preparing 5-biphenyl-4-amino-2 methyl pentanoic acid | |
| IL196234A0 (en) | A process for the preparation of optically active cyclopropylamines | |
| IL194522A0 (en) | Process for the preparation of prasugrel | |
| IL198330A0 (en) | Process for preparing 2-amino-5-cyanobenzoic acid derivatives | |
| ZA200903533B (en) | Process for the preparation of rosuvastatin | |
| EP2035410A4 (fr) | Procédé de préparation de l'ésoméprazole et de ses sels | |
| ZA201007625B (en) | Crystalline form of tenofovir disoproxil and a process for its preparation | |
| ZA200905601B (en) | Improved process for the preparation of ozidized phospholipids | |
| PL2220152T3 (pl) | Sposób otrzymywania kompozycji sieciującej | |
| PL2016045T3 (pl) | Krystaliczna postać tygecykliny i sposoby jej otrzymywania | |
| IL198388A0 (en) | Process for preparing 2-amino-5-cyanobenzoic acid derivatives | |
| PL2137206T3 (pl) | Sposób wytwarzania kwasu tauroursodeoksycholowego | |
| PL2358662T3 (pl) | Sposób amonolizy kwasu 11-bromoundekanowego | |
| ZA200907191B (en) | Process for the preparation of gefitiib | |
| PL2146944T3 (pl) | Sposób otrzymywania folianów znakowanych fluorem-18 | |
| ZA200809171B (en) | Process for the preparation of pyrazolylaminoquinazoline derivatives comprising a phosphate group | |
| PT2229062E (pt) | Processo de preparação de um hidrolisado | |
| EG25838A (en) | Process for the preparation of amino acid methyl esters | |
| ZA200800729B (en) | A crystalline form of the zoledronic acid, a process to obtain it and the pharmaceutical composition comprising it | |
| EP2170813A4 (fr) | Nouveau procédé pour la préparation de la prégabaline | |
| EP2046342A4 (fr) | Forme cristalline a de l'acide ibandronique et son procédé de préparation | |
| IL196618A0 (en) | A process for the preparation of lamotrigine | |
| IL186294A0 (en) | A process for the preparation of phenyltetrazole compounds | |
| IL198603A0 (en) | Process for the preparation of biphosphonic acids and salts thereof | |
| AU2007270897A8 (en) | Novel process for the preparation of bisphosphonic acids |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20090212 |
|
| AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR |
|
| AX | Request for extension of the european patent |
Extension state: AL BA HR MK RS |
|
| DAX | Request for extension of the european patent (deleted) | ||
| A4 | Supplementary search report drawn up and despatched |
Effective date: 20110401 |
|
| 17Q | First examination report despatched |
Effective date: 20130221 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 20130704 |